Many studies combined in a large review mention the relationship between glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) and inflammation, emphasizing the importance of GIP and GLP-1-dependent pathways in atherosclerosis and coronary heart disease, and say that GIP and GLP-1 can be used as markers of the frequency, clinical course and recurrence of coronary heart disease and are associated with the degree and severity of atherosclerosis and myocardial ischemia [9]. Here, GLP1R is linked to coronary artery disorder.